|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Morais C, Pat B, Gobe G, Johnson DW and
Healy H: Pyrrolidine dithiocarbamate exerts anti-proliferative and
pro-apoptotic effects in renal cell carcinoma cell lines. Nephrol
Dial Transplant. 21:3377–3388. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hong MH1, Kim HS, Kim C, Ahn JR, Chon HJ,
Shin SJ, Ahn JB, Chung HC and Rha SY: Treatment outcomes of
sunitinib treatment in advanced renal cell carcinoma patients: A
single cancer center experience in Korea. Cancer Res Treat.
41:67–72. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McDermott DF: Immunotherapy of metastatic
renal cell carcinoma. Cancer. 115(Suppl 10): S2298–S2305. 2009.
View Article : Google Scholar
|
|
5
|
Zhu L, Zhao L, Wang H, Wang Y, Pan D, Yao
J, Li Z, Wu G and Guo Q: Oroxylin A reverses
P-glycoprotein-mediated multidrug resistance of MCF7/ADR cells by
G2/M arrest. Toxicol Lett. 219:107–115. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Benabbou N, Mirshahi P, Cadillon M, Soria
J, Therwath A and Mirshahi M: Hospicells promote upregulation of
the ATP-binding cassette genes by insulin-like growth factor-I via
the JAK2/STAT3 signaling pathway in an ovarian cancer cell line.
Int J Oncol. 43:685–694. 2013.PubMed/NCBI
|
|
7
|
Harris AL and Hochhauser D: Mechanisms of
multidrug resistance in cancer treatment. Acta Oncol. 31:205–213.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kimura Y, Morita SY, Matsuo M and Ueda K:
Mechanism of multidrug recognition by MDR1/ABCB1. Cancer Sci.
98:1303–1310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kopnin BP: Targets of oncogenes and tumor
suppressors: Key for understanding basic mechanisms of
carcinogenesis. Biochemistry. Biokhimiia. 65:2–27. 2000.PubMed/NCBI
|
|
10
|
Lowe SW and Lin AW: Apoptosis in cancer.
Carcinogenesis. 21:485–495. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Desagher S and Martinou JC: Mitochondria
as the central control point of apoptosis. Trends Cell Biol.
10:369–377. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jin Z and El-Deiry WS: Overview of cell
death signaling pathways. Cancer Biol Ther. 4:139–163. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
D’Amours D, Desnoyers S, D’Silva I and
Poirier GG: Poly(ADP-ribosyl)ation reactions in the regulation of
nuclear functions. Biochem J. 342:249–268. 1999. View Article : Google Scholar
|
|
14
|
Flekhter OB, Medvedeva NI, Tolstikov GA,
Galin FZ, Iunusov MS, Huong NT, Le VT, Svinova OV, Boreko EI, Titov
LP, et al: Synthesis of olean-18(19)-ene derivatives from betulin.
Bioorg Khim. 35:253–259. 2009.In Russian. PubMed/NCBI
|
|
15
|
Yoo JH and Yang KS: Lupane triterpenoids
from Pyrus pyrifolia. Nat Prod Sci. 18:13–15. 2012.
|
|
16
|
Hwang CR, Oh SH, Kim HY, Lee SH, Hwang IG,
Shin YS, Lee JS and Jeong HS: Chemical composition and antioxidant
activity of Deoduk (Codonopsis lanceolate) and Doragi (Platycodon
grandiforum) according to temperature. J Korean Soc Food Sci Nutr.
40:798–803. 2011. View Article : Google Scholar
|
|
17
|
Akihisa T, Takamine Y, Yoshizumi K, Tokuda
H, Kimura Y, Ukiya M, Nakahara T, Yokochi T, Ichiishi E and Nishino
H: Microbial transformations of two lupane-type triterpenes and
anti-tumor-promoting effects of the transformation products. J Nat
Prod. 65:278–282. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Machado KE, Cechinel Filho V, Cruz RC,
Meyre-Silva C and Cruz AB: Antifungal activity of Eugenia
umbelliflora against dermatophytes. Nat Prod Commun. 4:1181–1184.
2009.PubMed/NCBI
|
|
19
|
Pyo JS, Roh SH, Kim DK, Lee JG, Lee YY,
Hong SS, Kwon SW and Park JH: Anti-cancer effect of Betulin on a
human lung cancer cell line: A pharmacoproteomic approach using 2 D
SDS PAGE coupled with nano-HPLC tandem mass spectrometry. Planta
Med. 75:127–131. 2009. View Article : Google Scholar
|
|
20
|
Li Y, He K, Huang Y, Zheng D, Gao C, Cui L
and Jin YH: Betulin induces mitochondrial cytochrome c release
associated apoptosis in human cancer cells. Mol Carcinog.
49:630–640. 2010.PubMed/NCBI
|
|
21
|
Yim NH, Cho WK, Lee JH, Jung YP, Yang HJ
and Ma JY: HRT, herbal formula, induces G2/M cell cycle
arrest and apoptosis via suppressing Akt signaling pathway in human
colon cancer cells. eCAM. 2012:871–893. 2012. View Article : Google Scholar
|
|
22
|
Kvasnica M, Sarek J, Klinotova E, Dzubak P
and Hajduch M: Synthesis of phthalates of betulinic acid and
betulin with cytotoxic activity. Bioorg Med Chem. 13:3447–3454.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y, Shen JT, Gao C, Li Q and Jin Y:
Caspase-9 activation, critical for betulin-induced apoptosis of
human hepatoma cells. Chem Res Chin Univ. 26:792–797. 2010.
View Article : Google Scholar
|
|
24
|
Szuster-Ciesielska A, Plewka K, Daniluk J
and Kandefer-Szerszeń M: Betulin and betulinic acid attenuate
ethanol-induced liver stellate cell activation by inhibiting
reactive oxygen species (ROS), cytokine (TNF-α, TGF-β) production
and by influencing intracellular signaling. Toxicology.
280:152–163. 2011. View Article : Google Scholar
|
|
25
|
Oh SH, Choi JE and Lim SC: Protection of
betulin against cadmium-induced apoptosis in hepatoma cells.
Toxicology. 220:1–12. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nuñez G, Benedict MA, Hu Y and Inohara N:
Caspases: The proteases of the apoptotic pathway. Oncogene.
17:3237–3245. 1998. View Article : Google Scholar
|
|
27
|
Wu GS: TRAIL as a target in anti-cancer
therapy. Cancer Lett. 285:1–5. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Green DR: Apoptotic pathways: Paper wraps
stone blunts scissors. Cell. 102:1–4. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Humphreys RC and Halpern W: Trail
receptors: Targets for cancer therapy. Adv Exp Med Biol.
615:127–158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wajant H: Increasing complexity in TNFR1
signaling. FEBS J. 278:8612011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Beg AA and Baltimore D: An essential role
for NF-kappaB in preventing TNF-alpha-induced cell death. Science.
274:782–784. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Van Antwerp DJ, Martin SJ, Kafri T, Green
DR and Verma IM: Suppression of TNF-alpha-induced apoptosis by
NF-kappaB. Science. 274:787–789. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Van Waes C: Nuclear factor-kappaB in
development, prevention, and therapy of cancer. Clin Cancer Res.
13:1076–1082. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Moriarty TJ, Dupuis S and Autexier C:
Rapid upregulation of telomerase activity in human leukemia HL-60
cells treated with clinical doses of the DNA-damaging drug
etoposide. Leukemia. 16:1112–1120. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Thompson Coon JS, Liu Z, Hoyle M, Rogers
G, Green C, Moxham T, Welch K and Stein K: Sunitinib and
bevacizumab for first-line treatment of metastatic renal cell
carcinoma: A systematic review and indirect comparison of clinical
effectiveness. Br J Cancer. 101:238–243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Porta C, Paglino C, Imarisio I, Ganini C
and Pedrazzoli P: Immunological effects of multikinase inhibitors
for kidney cancer: A clue for integration with cellular therapies?
J Cancer. 2:333–338. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kaewpiboon C, Srisuttee R, Malilas W, Moon
J, Kaowinn S, Cho IR, Johnston RN, Assavalapsakul W and Chung YH:
Extract of Bryophyllum laetivirens reverses etoposide resistance in
human lung A549 cancer cells by downregulation of NF-κB. Oncol Rep.
31:161–168. 2014.
|
